Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide

3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide

3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide structure

3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide 

structure
  • CAS No:

    781652-57-1

  • Formula:

    C23H16N4O

  • Chemical Name:

    3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide

  • Synonyms:

    Benzamide,3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)-;3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide;CDPPB;3-Cyano-N-(2,5-diphenylpyrazol-3-yl)benzamide;3-Cyano-N-(2,5-diphenyl-2H-pyrazol-3-yl)-benzamide

3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide Basic Attributes

364.406

364.40

DTXSID80459996

Characteristics

70.7

4.73628

white to beige

1.203g/cm3

207-208 °C

523.277ºC at 760 mmHg

270.268ºC

1.655

DMSO: ≥5mg/mL at warmed to 60°C

Store at +4°C

Safety Information

NONH for all modes of transport

3

22

Xn

P264, P270, P301+P312, P330, P501

H302

Drug Information

3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide

3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide Use and Manufacturing

CDPPB is a glutamate metabotropic (mGluR5) positive allosteric modulator, used in the treatment of Phelan-McDermid syndrome caused by 22qI3 deletion. Studies have shown that CDPPB suppresses the increase of LDH release and caspase-3 activation induced by traumatic neuronal injury.

Computed Properties

Molecular Weight:364.4
XLogP3:4.4
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:4
Exact Mass:364.13241115
Monoisotopic Mass:364.13241115
Topological Polar Surface Area:70.7
Heavy Atom Count:28
Complexity:572
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of 3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.